Dmello, C., Zhao, J., Chen, L., Gould, A., Castro, B., Arrieta, V. A., . . . Sonabend, A. M. (2023, March). Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade. Nature Communications.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Dmello, Crismita, et al. "Checkpoint Kinase 1/2 Inhibition Potentiates Anti-tumoral Immune Response and Sensitizes Gliomas to Immune Checkpoint Blockade." Nature Communications Mar. 2023.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Dmello, Crismita, et al. "Checkpoint Kinase 1/2 Inhibition Potentiates Anti-tumoral Immune Response and Sensitizes Gliomas to Immune Checkpoint Blockade." Nature Communications, Mar. 2023.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.
